Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Saba Ghassemi

4PUBLICATIONS

8CO-AUTHORS

Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Nanomedicine

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 02, 2025

Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia.

Chao Ma, Huishu Wang, Lunan Liu

|Feb 22, 2022

Rapid manufacturing of non-activated potent CAR T cells.

Saba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz

|Mar 24, 2018

CAR T cell immunotherapy for human cancer.

Carl H June, Roddy S O'Connor, Omkar U Kawalekar

|Nov 12, 2017

Heating up cancer vaccines.

Saba Ghassemi, Beatriz M Carreno

Pageof 1

Frequent Collaborators

2 joint publications

Michael C Milone

1 joint publications

Carl H June

1 joint publications

Katherine D Cummins

1 joint publications

Gabriela Plesa

1 joint publications

Roddy S O'Connor

1 joint publications

Chao Ma

1 joint publications

Huishu Wang

1 joint publications

Weiqiang Chen

Frequent Collaborators

2 joint publications

Michael C Milone

1 joint publications

Carl H June

1 joint publications

Katherine D Cummins

1 joint publications

Gabriela Plesa

Top Related Videos

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on : Mar 14, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on : Dec 17, 2019

See more related videos

Top Related Videos

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on : Mar 14, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on : Dec 17, 2019

See more related videos